Literature DB >> 24031366

Candida isolates in tertiary hospitals in northeastern Brazil.

Sylvia Lemos Hinrichsen1, Erica Falcão, Tatiana Aguiar Santos Vilella, Leandro Rêgo, Conceição Lira, Luciano Almeida, Mízia Martins, Carmem Araújo, Marcelo Duarte, Geraldo Lopes.   

Abstract

Candida is an opportunistic pathogen that affects high-risk patients who are either immunocompromised or critically ill and is associated with almost 80% of all nosocomial fungal infections, representing the major cause of fungemia with high mortality rates (40%). Candida albicans is the main cause of candidemia and among the non-albicans species C. parapsilosis, C. glabrata and C. tropicalis are the most frequent agents. The aim of this study was to evaluate the distribution of Candida species in two tertiary hospitals in Recife, Northeastern Brazil. It began by surveying all positive Candida cultures processed by the microbiology laboratory from September 2003 to September 2006. The cultures, originated from various types of biological material (blood, urine, tracheal, catheter and others), were processed by Vitec (®) system (Biomerieux SA, France). A total of 1.279 (hospital A: 837; hospital B: 442) sample isolates were positive for Candida. The most frequent species in both hospitals were: C. albicans (367), C. tropicalis (363), C. parapsilosis (147), C. glabrata (81), C. krusei (30) and C. guillermondii (14). The isolates were obtained from 746 hospitalized patients. A total of 221 positive hemocultures were detected in 166 different patients in both hospitals, and 113 (68.1%) of these patients with positive hemocultures presented Candida in other body sites. This study shows that Candida non-albicans was the main isolated agent and evidences the importante of C. tropicalis in nosocomial fungal infections.

Entities:  

Keywords:  Candida; candida isolates; candidemia

Year:  2009        PMID: 24031366      PMCID: PMC3769710          DOI: 10.1590/S1517-838220090002000021

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


Candida is an opportunistic pathogen that affects high-risk patients who are either immunocompromised or critically ill (4,6,14,15). Throughout the 1990s, the incidence of invasive fungal infections such candidiasis increased significantly worldwide, a concern because invasive fungal infections which are also difficult to diagnose, prevent, and treat (7,14,15,17). Candida is associated with almost 80% of all nosocomial fungal infections, representing the major cause of fungemia with high mortality rates (40%) (4,6,8,14). Candida albicans is the main cause of candidemia and among the non-albicans species C. parapsilosis, C. glabrata and C. tropicalis are the most frequent agents (4,6,7,14,18). Studies have demonstrated direct association between the number of body sities colonized and the incidence of candidiasis. Cultures are positive in only 50% of patients with invasive candidiasis, and diagnosis is confirmed ant mortens in only 15 to 40% of cases (4,6,7,14,15,18,19,23). The aim of this study is to evaluate the distribution of Candida species in tertiary hospitals in Northeastern Brazil. This observational prospective study was performed at two tertiary private hospitals (hospital A: 217 beds; hospital B: 54 beds) in Recife, Pernambuco state, northeastern, Brazil. It began by surveying all positive Candida cultures processed by the microbiology laboratory from September 2003 to September 2006. A database was created with the following variables: age, gender, types of biological material, including urine, blood and other body sites and Candida species distribution. During this period, all cultures originated from various types of biological material (blood, urine, tracheal, catheter and others) were processed by Vitecsystem (Biomerrieux SA, France). Cultures were processed in accordance with NCCLS- National Committee for Clinical Laboratory Standards (14). The statistical analysis was performed with the Epi-Info-6.04 software through descriptive analysis for relative frequency and prevalence. The study protocol was approved by the Institutional Ethics Committee (Nº 1263/2003) and the resources for the development of the project were obtained from Cerpe Diagnosticos. During the period of study, a total of 1.279 sample isolates were positive to Candida in both hospitals (Hospital A: n= 837; Hospital B: n= 442) and the isolates were obtained from different body sites from 746 hospitalized patients (Hospital A: n= 496; Hospital B: n= 250) (Tables 1 and 2). The age of patients ranged from zero to 101 years with mean of 61.5 years (Median = 69 years), and 55.1% were female and 44,9%, male.
Table 1

Identification and sources of all 837 Candida spp. isolates, between September, 2003 and September, 2006 in the Hospital A in Recife, PE, Brazil.

SPECIES(Number)BloodUrineTrachealCatheterMiscellaneous**
C. albicans(253)18(7.1%)62(24.5%)105(41.5%)15(5.9%)53(20.9%)
C.tropicalis(228)30(13.2%)45(19.7%)89(39.0%)31(13.6)33(14.5%)
C. parapsilosis(96)42(43.8%)6(6.3%)5(5.2%)31(32.3%)12(12.5%)
C. glabrata(59)9(15.3%)31(52.5%)8(13.6%)1(1.7%)10(16.9%)
C. guilliermondii(7)4 (57.1%)0(0%)2(28.6%)0(0%)1(14.3%)
C. krusei(18)3(16.7%)2(11.1%)2(11.1%)4(22.2%)7(38.9%)
C. lusitaniae(6)0(0%)2(33.3%)4(66.7%)0(0%)0(0%)
C. famata(4)0(0%)0(0%)3(75.0%)1(25.0%)0(0%)
Candida spp.(166)3(1.8%)41(24.7%)23(13.9%)7(4.2%)92(55.4%)
Total837109(13.0%)189(22.6%)241(28.8%)90(10.8%)208 (24.9%)

Hospital A: 217 beds

Miscellaneous: wound material and others.

Table 2

Identification and sources of all 442 Candida spp. isolates, between September, 2003 and September, 2006 in the Hospital B in Recife, PE, Brazil.

SPECIES(Number)BloodUrineTrachealCatheterMiscellaneous**
C. albicans(114)23(20.2%)27(23.7%)18(15.8%)6(5.3%)40(35.1%)
C.tropicalis(135)44(32.6)19(14.1%)29(21.5%)13(9.6%)30(22.2%)
C.parapsilosis(51)32(62.7%)3(5.9%)4(7.8%)7(13.7%)5(9.8%)
C.glabrata(22)2(9.1%)12(54.5%)4(18.2%)0(0%)4(18.2%)
C.guillermondi(7)3(42.9%)0(0%)1(14.3%)1(14.3%)2(28.6%)
C. krusei(12)5(41.7%)1(8.3%)3(25.0%)1(8.3%)2(16.7%)
C. lusitaniae(2)1(50.0%)0(0%)1(50.0%)0(0%)0(0%)
C. famata(3)1(33.3%)0(0%)1(33.3%)1(33.3%)0(0%)
Candida spp.(96)1(1.0%)25(26.0%)24(25.0%)6(6.3%)40(41.7%)
Total442112(25.3%)87(19.7%)85 (19.2%)35(7.9%)123(27.8%)

Hospital B: 54 beds

Miscellaneous: wound material and others.

Identification and sources of all 837 Candida spp. isolates, between September, 2003 and September, 2006 in the Hospital A in Recife, PE, Brazil. Hospital A: 217 beds Miscellaneous: wound material and others. Identification and sources of all 442 Candida spp. isolates, between September, 2003 and September, 2006 in the Hospital B in Recife, PE, Brazil. Hospital B: 54 beds Miscellaneous: wound material and others. The most frequent species in both hospitals were: C. albicans n= 367; C. tropicalis n= 363; C. parapsilosis n= 147; C. glabrata n= 81; C. krusei n= 30; C. guillermondii n=14 (Tables 1 and 2). A total of 221 positive hemocultures were detected in 166 different patients in both hospitals. 113 (68.1%) of these patients with positive hemocultures presented Candida in other body sites (Tables 1 and 2). Brazilian reports (in public tertiary hospitals at southeastern) have revealed that C. albicans is the main agent of candidemia (20-50%), followed by C. parapsilosis (17-35%), C. tropicalis (12- 27%), and C. guilliermondii (2-10%) (2,9). The appearance of non-albicans isolates among patients admitted to tertiary care hospitals have been reported by different centers, including medical institutions from Brazil (1,4,8,14,18,20). In a candidemia study in a reference public tertiary hospital in Fortaleza, Ceará (Northeast Brazil) non- albicans species of Candida, were responsible for a total of 72% of fungemia cases. C. parapsilois (n= 18) was the most isolated agent, followed by C. albicans (n= 14), C. tropicalis (n= 8), C. guillermonddii (n= 6), C. glabrata (n= 2) and Candida spp. (n= 2) (14). In our study C. parapsilosis and C. tropicalis were the most frequent agents isolated in blood (n= 148; 67,0%). The increased use of invasive medical procedures as well as the prophylactic and empirical use of antifungal drugs, especially those of azolic derivation, has been blamed for the emergence of the non-albicans species of Candida (10,12,19). C. parapsilosis is widely recognized as a cause of fungemia among hospitalized patients (4,14). C. parapsilosis is part of the endogenous microbiota of human beings and is a commensal organism, which penetrates the blood by rupting the sikin. The yeast is capable of forming biofilm in gucosilated solutions and adhering to plastic materials, such as catheters used for parenteral nutrition. Over the last few years, outbreaks and clusters of cross-transmission, total parenteral nutrition solutions, intravascular devices, and medications have been related to C. parapsilosis fungemia (5,10,21). In addition, C. parapsilosis is an important pathogen of onychomycosis in fingernails (3,11). C. tropicalis presents as an important cause of fungemia in oncological and nononcological patients with diabetes, central venous catheters taking broad-spectrum antibiotics. The risk factors and presentation of C. tropicalis fungemia in comparison to that of C. albicans have been incompletely characterized (3,17,19). Most infections appear to originate from the patients’ alimentary tract microflora (22). The higher proportion of C. tropicalis in adult patients and older children hospitalized in oncology-hematology units might be partially explained by the prophylactic or empirical use of antifungal drugs (19). However, other differences, such as host defense deficiency and mucosal integrity, may be related to this discrepancy. C. tropicalis appears to be more virulent than C. albicans in patients with hematological malignancies, and disseminated infection is associated with high mortality rates (3,11,12). Among adults with or without cancer, systemic infections due to C. tropicalis have been associated with higher rates of mortality and dissemination than infection due to C. parapsilosis (3,4,12). Contrary to the United States and Europe where C. glabrata is the second or third most commonly species of Candida isolated from patients with invasive infections (20), C. glabrata and C. krusei isolates together represented only 8,8% of all yeast isolates in our study in Northeastern Brazil. In agreement with data reported by other investigators in Southeastern, Brazil who found 9,0%, but higher than in other study in Northeastern, Brazil (5,0%) (2,9). Concluding, our study confirmed data from previous studies that demonstrated high prevalence of candidemia in Brazil caused by species other than C. albicans, and shows that Candida non-albicans was the main isolated agent and evidences the importante of C. tropicalis and also, C. parapsilosis, in nosocomial fungal infections.
  21 in total

1.  High rate of non-albicans candidemia in Brazilian tertiary care hospitals.

Authors:  A L Colombo; M Nucci; R Salomão; M L Branchini; R Richtmann; A Derossi; S B Wey
Journal:  Diagn Microbiol Infect Dis       Date:  1999-08       Impact factor: 2.803

2.  Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  The epidemiology of hematogenous candidiasis caused by different Candida species.

Authors:  D Abi-Said; E Anaissie; O Uzun; I Raad; H Pinzcowski; S Vartivarian
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

4.  Hospital-acquired candidemia. The attributable mortality and excess length of stay.

Authors:  S B Wey; M Mori; M A Pfaller; R F Woolson; R P Wenzel
Journal:  Arch Intern Med       Date:  1988-12

5.  Cluster of Candida parapsilosis primary bloodstream infection in a neonatal intensive care unit.

Authors:  C L da Silva; R M dos Santos; A L Colombo
Journal:  Braz J Infect Dis       Date:  2001-02       Impact factor: 1.949

6.  Fluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method.

Authors:  Arnaldo L Colombo; Daniel Da Matta; Leila Paula De Almeida; Robert Rosas
Journal:  Braz J Infect Dis       Date:  2002-06       Impact factor: 1.949

7.  Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital.

Authors:  Thomas A Clark; Sally A Slavinski; Juliette Morgan; Timothy Lott; Beth A Arthington-Skaggs; Mary E Brandt; Risa M Webb; Mary Currier; Richard H Flowers; Scott K Fridkin; Rana A Hajjeh
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Candidemia in a Brazilian hospital: the importance of Candida parapsilosis.

Authors:  Delia Jessica Astete Medrano; Raimunda Sâmia Nogueira Brilhante; Rossana de Aguiar Cordeiro; Marcos Fábio Gadelha Rocha; Silvia Helena Barem Rabenhorst; José Júlio Costa Sidrim
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2006-03-09       Impact factor: 1.846

9.  Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis.

Authors:  T J Walsh; W G Merz
Journal:  Am J Clin Pathol       Date:  1986-04       Impact factor: 2.493

10.  Fungemia in cancer patients in Brazil: predominance of non-albicans species.

Authors:  M Nucci; M I Silveira; N Spector; F Silveira; E Velasco; C A Martins; A Derossi; A L Colombo; W Pulcheri
Journal:  Mycopathologia       Date:  1998       Impact factor: 2.574

View more
  4 in total

1.  Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis.

Authors:  João B A Neto; Cecília R da Silva; Maria A S Neta; Rosana S Campos; Janaína T Siebra; Rose A C Silva; Danielle M Gaspar; Hemerson I F Magalhães; Manoel O de Moraes; Marina D P Lobo; Thalles B Grangeiro; Tatiane S C Carvalho; Emilay B T Diogo; Eufrânio N da Silva Júnior; Felipe A R Rodrigues; Bruno C Cavalcanti; Hélio V N Júnior
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

2.  Fungemia caused by Candida species in a children's public hospital in the city of São Paulo, Brazil: study in the period 2007-2010.

Authors:  Vanessa Kummer Perinazzo Oliveira; Luciana da Silva Ruiz; Nélio Alessandro Jesus Oliveira; Débora Moreira; Rosane Christine Hahn; Analy Salles de Azevedo Melo; Angela Satie Nishikaku; Claudete Rodrigues Paula
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jul-Aug       Impact factor: 1.846

3.  Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.

Authors:  Catarina Savastano; Elisa de Oliveira Silva; Lindyanne Lemos Gonçalves; Jéssica Maria Nery; Naiara Chaves Silva; Amanda Latercia Tranches Dias
Journal:  Braz J Microbiol       Date:  2016-03-02       Impact factor: 2.476

4.  Rapid Detection of Echinocandins Resistance by MALDI-TOF MS in Candida parapsilosis Complex.

Authors:  Ana Emília M Roberto; Danilo E Xavier; Esteban E Vidal; Cláudia Fernanda de L Vidal; Rejane P Neves; Reginaldo G de Lima-Neto
Journal:  Microorganisms       Date:  2020-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.